This excerpt taken from the EYE 8-K filed Oct 31, 2008.
Refractive sales declined 14.4% to $96.0 million.
Procedures, implants and related sales declined 11.3% to $67.2 million, as growth in Japan and Asia Pacific was unable to offset significant declines in the U.S.
AMOs U.S. excimer procedure volumes declined approximately 35% in the third quarter and approximately 17% for the trailing 12 months ended September 26,
2008; the companys U.S. custom mix was 69.5% in the third quarter and 67.6% for the trailing 12 months ended September 26, 2008.
AMOs U.S. femtosecond procedure volumes declined approximately 12% in the third quarter and rose approximately 14% for the trailing 12 months ended
September 26, 2008, on a pro forma basis.
AMOs international procedure, implant and related sales were $31.7 million, up 33.1%, reflecting strong growth in Japan and Asia Pacific.
System sales declined 31.2% to $18.8 million, reflecting a sharp pullback in new equipment purchases by LASIK providers on a global basis.
How risky is your portfolio?
Remember that 401k from 2 jobs ago?
Taking on too much risk? Too little risk? Have no idea?
Skip the spreadsheet. Track your investments automatically.
We tally your portfolio fees so you don't have to.
You're probably paying higher fees than you think.
Translate your investment accounts from Martian to English.